Zobrazeno 1 - 10
of 197
pro vyhledávání: '"Christopher G. AZZOLI"'
Autor:
Tej Tummala, Ashley Sanchez Sevilla Uruchurtu, Arielle De La Cruz, Kelsey E. Huntington, Andrew George, Nicholas R. Liguori, Leiqing Zhang, Lanlan Zhou, Abbas E. Abbas, Christopher G. Azzoli, Wafik S. El-Deiry
Publikováno v:
Current Oncology, Vol 30, Iss 11, Pp 9611-9626 (2023)
Pancreatic cancer is a devastating disease with a poor prognosis. Novel chemotherapeutics in pancreatic cancer have shown limited success, illustrating the urgent need for new treatments. Lurbinectedin (PM01183; LY-01017) received FDA approval in 202
Externí odkaz:
https://doaj.org/article/baef67e61ff84cad80cfd50ebbb42934
Autor:
Brett H. Diamond, MD, Neel Belani, MD, Rebecca Masel, MD, Kathryn DeCarli, MD, MBE, Thomas DiPetrillo, MD, Jaroslaw T. Hepel, MD, Christopher G. Azzoli, MD, Humera Khurshid, MD, Abbas Abbas, MD, Paul P. Koffer, MD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 2, Pp 101130- (2023)
Purpose: In patients with locally advanced, unresectable non-small cell lung cancer (NSCLC), the standard of care is concurrent chemoradiation (CRT) followed by consolidative immunotherapy with durvalumab. Pneumonitis is a known adverse event of both
Externí odkaz:
https://doaj.org/article/1d82d7753a82465b8c3feb213e3b1ccd
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 6, Iss C, Pp 21-23 (2017)
Purpose: To report two new cases of presumed erlotinib-associated bilateral acute simultaneous-onset anterior uveitis effectively treated with topical steroids. Observations: Two patients were referred to the uveitis clinic with bilateral acute simul
Externí odkaz:
https://doaj.org/article/965ecc3592774ca8b054388ae05fcd49
Autor:
Giuseppe GIACCONE, David TRENT, John R. STRAWN, Reily SMITH, Thomas J. SMITH, Joan H. SCHILLER, David G. PFISTER, Steven PIANTADOSI, Luke NORDQUIST, Daniel MILTON, Gregory MASTERS, Janessa L. LASKI, David H. JOHNSON, Julie BRAHMER, William PAO, Timothy ALIFF, Sarah TEMIN, Sherman Baker JR, Christopher G. AZZOLI
Publikováno v:
Chinese Journal of Lung Cancer, Vol 13, Iss 3, Pp 171-189 (2010)
Externí odkaz:
https://doaj.org/article/4c40e597843b41f7b295cbd8bfd46afe
Autor:
Aaron N. Hata, Paul E. Hughes, Cyril H. Benes, Angela Coxon, Sean P. Brown, Kristopher A. Sarosiek, Justin F. Gainor, Christopher G. Azzoli, Anna F. Farago, Zofia Piotrowska, Lecia V. Sequist, Colleen Keyes, John H. Shin, Daniel P. Cahill, Kevin A. Raskin, Cameron D. Wright, Michael Lanuti, Lorin A. Ferris, Kristof Vajda, Diamanda Rigas, Cameron Fraser, Chendi Li, Hannah L. Archibald, Maria Gomez-Caraballo, Nicole Phan, Samantha J. Bilton, Daria Timonina, Sean Caenepeel, Faria M. Siddiqui, Varuna Nangia
BH3 mimetic drugs, which inhibit prosurvival BCL2 family proteins, have limited single-agent activity in solid tumor models. The potential of BH3 mimetics for these cancers may depend on their ability to potentiate the apoptotic response to chemother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70abe6bdd9a6b3e57487dfcfd1b546b5
https://doi.org/10.1158/2159-8290.c.6547298.v1
https://doi.org/10.1158/2159-8290.c.6547298.v1
Autor:
Aaron N. Hata, Paul E. Hughes, Cyril H. Benes, Angela Coxon, Sean P. Brown, Kristopher A. Sarosiek, Justin F. Gainor, Christopher G. Azzoli, Anna F. Farago, Zofia Piotrowska, Lecia V. Sequist, Colleen Keyes, John H. Shin, Daniel P. Cahill, Kevin A. Raskin, Cameron D. Wright, Michael Lanuti, Lorin A. Ferris, Kristof Vajda, Diamanda Rigas, Cameron Fraser, Chendi Li, Hannah L. Archibald, Maria Gomez-Caraballo, Nicole Phan, Samantha J. Bilton, Daria Timonina, Sean Caenepeel, Faria M. Siddiqui, Varuna Nangia
Supplementary Figure 1-5, Supplementary Tables 1-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d14dcf58051aa128a6d420a7ae16b05
https://doi.org/10.1158/2159-8290.22533896.v1
https://doi.org/10.1158/2159-8290.22533896.v1
Autor:
Mari Mino-Kenudson, Jeffrey A. Engelman, Beow Y. Yeap, Yukako Yagi, Aaron N. Hata, Teresa Moran, Subba Digumarthy, James R. Stone, Ryan J. Sullivan, Anna F. Farago, Emily Howe, Katherine R. Schultz, Linnea Fulton, Ling Zhao, Tiffany G. Huynh, Zofia Piotrowska, Christopher G. Azzoli, Xiujun Fu, Lecia V. Sequist, Alice T. Shaw, Justin F. Gainor
A-C): Images of autopsy specimens from an ALK-positive NSCLC patient, demonstrating heterogeneous expression of PD-L1 in multiple sections examined (Diffuse PD-L1 expression in A-B and focal PD-L1 expression in C).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a96f2f0b51a73f2f6f235a92e4980781
https://doi.org/10.1158/1078-0432.22463468
https://doi.org/10.1158/1078-0432.22463468
Autor:
Lee M. Krug, Mark G. Kris, Gregory J. Riely, Christopher G. Azzoli, Naiyer A. Rizvi, Timothy A. Chan, Andrei I. Holodny, Michelle S. Ginsberg, Adriana Heguy, William D. Travis, Dyana K. Sumner, John J. Fiore, Camelia S. Sima, Kety Huberman, Kyuichi Kadota, M. Catherine Pietanza
PDF file - 39K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a3040e360d2af948eb11e1725328e81
https://doi.org/10.1158/1078-0432.22443855
https://doi.org/10.1158/1078-0432.22443855
Autor:
Aaron N. Hata, Alice T. Shaw, Justin F. Gainor, Michael S. Lawrence, Christopher G. Azzoli, Cyril H. Benes, Rebecca J. Nagy, Ashish Saxena, Subba R. Digumarthy, Sara E. Stevens, Hetal D. Marble, Andrew Do, Emily Chin, Beow Y. Yeap, Nathaniel A. Adams, Audris Oh, Kylie Prutisto-Chang, Marguerite M. Rooney, Jessica J. Lin, Adam Langenbucher, Jochen K. Lennerz, Satoshi Yoda, Ibiayi Dagogo-Jack
Supplementary Figure 1-5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0215f8f24d8afb225e3d4d70729bf487
https://doi.org/10.1158/1078-0432.22478531.v1
https://doi.org/10.1158/1078-0432.22478531.v1
Autor:
Mari Mino-Kenudson, Jeffrey A. Engelman, Beow Y. Yeap, Yukako Yagi, Aaron N. Hata, Teresa Moran, Subba Digumarthy, James R. Stone, Ryan J. Sullivan, Anna F. Farago, Emily Howe, Katherine R. Schultz, Linnea Fulton, Ling Zhao, Tiffany G. Huynh, Zofia Piotrowska, Christopher G. Azzoli, Xiujun Fu, Lecia V. Sequist, Alice T. Shaw, Justin F. Gainor
Purpose: PD-1 inhibitors are established agents in the management of non–small cell lung cancer (NSCLC); however, only a subset of patients derives clinical benefit. To determine the activity of PD-1/PD-L1 inhibitors within clinically relevant mole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cbdcf42c28c87d5a05f8ad58838aa5f
https://doi.org/10.1158/1078-0432.c.6525413
https://doi.org/10.1158/1078-0432.c.6525413